Your browser doesn't support javascript.
loading
Leveraging machine learning to enhance postoperative risk assessment in coronary artery bypass grafting patients with unprotected left main disease - A retrospective cohort study.
Elmahrouk, Ahmed; Daoulah, Amin; Panduranga, Prashanth; Rajan, Rajesh; Jamjoom, Ahmed; Kanbr, Omar; Alzahrani, Badr; Qutub, Mohammed A; Yousif, Nooraldaem; Chachar, Tarique Shahzad; Elmahrouk, Youssef; Alshehri, Ali; Hassan, Taher; Tawfik, Wael; Haider, Kamel Hazaa; Abohasan, Abdulwali; Alqublan, Adel N; Alqahtani, Abdulrahman M; Ghani, Mohamed Ajaz; Al Nasser, Faisal Omar M; Almahmeed, Wael; Ghonim, Ahmed A; Hashmani, Shahrukh; Alshehri, Mohammed; Elganady, Abdelmaksoud; Shawky, Abeer M; Fathey Hussien, Adnan; Abualnaja, Seraj; Noor, Taha H; Abdulhabeeb, Ibrahim A M; Ozdemir, Levent; Refaat, Wael; Kazim, Hameedullah M; Selim, Ehab; Altnji, Issam; Ibrahim, Ahmed M; Alquaid, Abdullah; Arafat, Amr A.
Affiliation
  • Elmahrouk A; Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.
  • Daoulah A; Department of Cardiothoracic Surgery, Faculty of Medicine, Tanta University, Egypt.
  • Panduranga P; Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.
  • Rajan R; Department of Cardiology, National Heart Center, Royal Hospital, Muscat, Sultanate of Oman.
  • Jamjoom A; Department of Cardiology, Sabah Al Ahmad Cardiac Center, Al Amiri Hospital, Sharq, Kuwait.
  • Kanbr O; Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.
  • Alzahrani B; Faculty of Medicine, Elrazi University, Khartoum, Sudan.
  • Qutub MA; Department of Cardiology, Prince Sultan Cardiac Center, Riyadh, Kingdom of Saudi Arabia.
  • Yousif N; Cardiology Center of Excellence, Department of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
  • Chachar TS; Department of Cardiology, Mohammed Bin Khalifa Specialist Cardiac Center, Awali, Kingdom of Bahrain.
  • Elmahrouk Y; Department of Cardiology, Mohammed Bin Khalifa Specialist Cardiac Center, Awali, Kingdom of Bahrain.
  • Alshehri A; Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Hassan T; Department of Cardiology, College of Medicine, King Khalid University, Abha, kingdom of Saudi Arabia.
  • Tawfik W; Department of Cardiology, Bugshan General Hospital, Jeddah, Kingdom of Saudi Arabia.
  • Haider KH; Department of Cardiology, Bugshan General Hospital, Jeddah, Kingdom of Saudi Arabia.
  • Abohasan A; Department of cardiology, Prince Sultan Cardiac Center, Qassim, Kingdom of Saudi Arabia.
  • Alqublan AN; Department of cardiology, Prince Sultan Cardiac Center, Qassim, Kingdom of Saudi Arabia.
  • Alqahtani AM; Department of Cardiology, King Salman Heart Center, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
  • Ghani MA; Department of Cardiology, King Salman Heart Center, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
  • Al Nasser FOM; Department of Cardiology, Madinah Cardiac Center, Madinah, kingdom of Saudi Arabia.
  • Almahmeed W; Department of Cardiology, Madinah Cardiac Center, Madinah, kingdom of Saudi Arabia.
  • Ghonim AA; Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, UAE.
  • Hashmani S; Cardiology Center of Excellence, Department of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
  • Alshehri M; Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, UAE.
  • Elganady A; Department of Cardiology, Prince Khaled Bin Sultan Cardiac Center, Khamis Mushait, Kingdom of Saudi Arabia.
  • Shawky AM; Department of Cardiology, Dr Erfan and Bagedo General Hospital, Jeddah, Kingdom of Saudi Arabia.
  • Fathey Hussien A; Department of Cardiology, Faculty of Medicine, Alazhr University, Cairo, Egypt.
  • Abualnaja S; Department of Cardiology, Dr Erfan and Bagedo General Hospital, Jeddah, Kingdom of Saudi Arabia.
  • Noor TH; Department of Cardiology, Faculty of Medicine, Alazhr University, Cairo, Egypt.
  • Abdulhabeeb IAM; Department of Cardiology, International Medical Center, Jeddah, Kingdom of Saudi Arabia.
  • Ozdemir L; Department of Cardiology, International Medical Center, Jeddah, Kingdom of Saudi Arabia.
  • Refaat W; Department of Cardiology, King Abdulaziz Specialist Hospital, Al Jawf, Kingdom of Saudi Arabia.
  • Kazim HM; Department of Cardiology, King Abdulaziz Specialist Hospital, Al Jawf, Kingdom of Saudi Arabia.
  • Selim E; Department of Cardiology, King Fahad Specialist Hospital, Tabuk, Kingdom of Saudi Arabia.
  • Altnji I; Department of Cardiology, Prince Sultan Cardiac Center, Al Hassa , Kingdom of Saudi Arabia.
  • Ibrahim AM; Department of Cardiology, Alhada Armed Forces Hospital, Taif, Kingdom of Saudi Arabia.
  • Alquaid A; Department of Cardiology, Alhada Armed Forces Hospital, Taif, Kingdom of Saudi Arabia.
  • Arafat AA; Department of Cardiology, St James's Hospital, Dublin, Ireland.
Int J Surg ; 2024 Aug 08.
Article in En | MEDLINE | ID: mdl-39116452
ABSTRACT

BACKGROUND:

Risk stratification for patients undergoing coronary artery bypass surgery (CABG) for left main coronary artery (LMCA) disease is essential for informed decision-making. This study explored the potential of machine learning (ML) methods to identify key risk factors associated with mortality in this patient group.

METHODS:

This retrospective cohort study was conducted on 866 patients from the Gulf Left Main Registry who presented between 2015 and 2019. The study outcome was hospital all-cause mortality. Various machine learning models [logistic regression, random forest (RF), k-nearest neighbor, support vector machine, naïve Bayes, multilayer perception, boosting] were used to predict mortality, and their performance was measured using accuracy, precision, recall, F1 score, and area under the receiver operator characteristic curve (AUC).

RESULTS:

Nonsurvivors had significantly greater EuroSCORE II values (1.84 (10.08-3.67) vs. 4.75 (2.54-9.53) %, P<0.001 for survivors and nonsurvivors, respectively). The EuroSCORE II score significantly predicted hospital mortality (OR 1.13 (95% confidence interval 1.09-1.18), P<0.001), with an AUC of 0.736. RF achieved the best ML performance (accuracy=98, precision=100, recall=97 and F1 score=98). Explainable artificial intelligence using SHAP demonstrated the most important features as follows preoperative lactate level, emergency surgery, chronic kidney disease (CKD), NSTEMI, nonsmoking status, and sex. QLattice identified lactate and CKD as the most important factors for predicting hospital mortality this patient group.

CONCLUSION:

This study demonstrates the potential of ML, particularly the Random Forest, to accurately predict hospital mortality in patients undergoing CABG for LMCA disease and its superiority over traditional methods. The key risk factors identified, including preoperative lactate levels, emergency surgery, chronic kidney disease, NSTEMI, nonsmoking status, and sex, provide valuable insights for risk stratification and informed decision-making in this high-risk patient population. Additionally, incorporating newly identified risk factors into future risk scoring systems can further improve mortality prediction accuracy.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Surg Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Surg Year: 2024 Document type: Article Country of publication: